Pathological diagnosis and clinical characteristics of cerebral amyloid angiopathy-related intracerebral hemorrhage

Pathological diagnosis and clinical characteristics of cerebral amyloid angiopathy-related intracerebral hemorrhage - Pathological diagnosis and clinical characteristics of CAA-ICH

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014542

Enrollment

Registered

2014-07-14

Start date

2014-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral amyloid angiopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with subcortical hemorrhage who undergo hematoma evacuation surgery and biopsy of hematoma and cerebral parenchyma for pathological diagnosis. Written informed consent about the objects, methods, expected results and hazard of this study must be obtained from the patients. In patients who had underwent craniotomy and biopsy for pathological survey before an application of this study, surgical consent form and informed consent about biopsy for pathological survey documented in medical records can be regarded as a written informed consent for this study.

Exclusion criteria

Exclusion criteria: Cases with subcortical hemorrhages which are derived from causes other than CAA.

Design outcomes

Primary

Measure	Time frame
We will clarify clinical characteristics and efficacy of pathological diagnosis of CAA-ICH. We will establish the method of clinical diagnosis and treatment of CAA.	—

Countries

Japan

Contacts

Public ContactTadashi Doden

Aizawa Hospital Department of Neurology

aidr214@ai-hosp.or.jp0263-33-8600

Outcome results